PODD

Insulet Corporation

Price

$201.49

return (12m)

p/e

37.78

p/bv

8.78

DIVIDEND YIELD

0.00%

PODD price

Insulet

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PODD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals PODD

Valuation

P/E

37.78

Sector -2.34

Industry 11.10

P/BV

8.78

Sector 2.17

Industry 3.33

P/Revenue (PSR)

3.94

Sector 2.00

Industry 1.71

EV/EBITDA

77.25

Sector -23.69

Industry -398.52

EV/EBIT

93.10

Sector -36.60

Industry -80.73

P/EBITDA

20.28

Sector -0.10

Industry 8.30

P/EBIT

24.38

Sector -2.08

Industry 5.69

P/Total Assets

3.83

Sector 1.18

Industry 1.57

P/Net Current Assets

459.44

Sector -10.91

Industry -3.38

P/Working Capital

11.19

Sector 0.09

Industry 10.51

EPS

4.33

Sector -0.93

Industry 1.10

BVPS

18.61

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

71.01%

Sector 44.28%

Industry 29.23%

EBITDA Margin

20.20%

Sector -291.45%

Industry 4.29%

EBIT Margin

16.77%

Sector -195.44%

Industry 1.44%

Operating Margin

17.49%

Sector -25.72%

Industry 2.16%

Net Profit Margins

10.44%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.25

Sector 0.12

Industry 0.27

Profitability

ROE

23.25%

Sector -34.71%

Industry 6.97%

ROA

10.14%

Sector -28.76%

Industry 2.97%

ROIC

18.66%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

0.00%

Sector -

Industry 0.54%

Debt

Current Ratio

2.49

Sector 1.87

Industry 1.51

Net Debt / EBITDA

2.92

Sector -2.18

Industry -1.68

Net Debt / EBIT

3.52

Sector -0.74

Industry -7.00

Net Debt / Equity

0.34

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.71

Sector -0.64

Industry 0.35

Equity/Assets

0.44

Sector 0.43

Industry 0.46

Liabilities/Assets

0.56

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

21.43%

Sector -

Industry -

5Y Earnings CAGR

78.31%

Sector -

Industry -

FAIR VALUE OF Insulet ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$201.49

Fair Value

$42.58

Upside Return potential.

-78.87%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PODD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PODD Insulet Corporation	$201.49	-20.67%	0.00%	37.78	8.78	23.25%	10.44%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PODD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Insulet

Insulet Corporation

Average Investor10 user rating

4.0 (0 people)

States of America

26 years

Founded: 2000

2007

Time since IPO - 19 years

1.350

Employees

Insulet Corporation (States of America) is listed on the Nasdaq and has a market capitalization of $11.44 billion, with shareholders equity totaling $1.30 billion.

The company employs approximately 1.350 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Insulet Corporation reported $2.90 billion in revenue, generating net income of $302.80 million.

Key financial metrics include a P/E ratio of 37.78, a price-to-book (P/B) ratio of 8.78, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PODD.

Market cap

$11.44 billion

Net worth

$1.30 billion

$1,302,600,000.00

Assets

$2.99 billion

$2,987,200,000.00

Total Shares Outstanding

70.00 million

70,000,000

Average Daily Trading Volume

$1.62 million

$1,619,812.00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

PODD

PODD revenue and profits

Financial Results PODD

DRAG THE FRAME TO SEE MORE DATA

PODD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56